Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02137759
Title MRSI to Predict Response to RT/TMZ and Vorinostat in GBM
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Emory University/Winship Cancer Institute Atlanta Georgia 30322 United States Details
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21287 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field